# "Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"

> **NCT00881543** · NA · COMPLETED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 45 (actual)

## Conditions studied

- Diabetes Type 2

## Interventions

- **DRUG:** Dipeptidyl Peptidase IV inhibitors

## Key facts

- **NCT ID:** NCT00881543
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-06
- **Final completion:** 2011-10
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2012-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00881543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00881543, ""Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00881543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*